Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Helius Medical Technologies Inc (NQ: HSDT )

0.5650 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Helius Medical Technologies Inc

< Previous 1 2 3 4 5 6 7 8 Next >
Helius Medical Technologies, Inc. Announces Alignment with FDA on Registrational Program for Treatment of Stroke Patients
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Helius Booth and Special Event at APTA Combined Sections Meeting Will Highlight Physical Therapists’ Ability to Customize PoNS Therapy® to Improve Gait in People with MS
Event Appearance Caps Year of Growth: PoNS®-Trained PTs Now Found Across the United States 
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Helius Medical Technologies, Inc. Announces Further Expansion of Stroke Clinical Program with the Addition of Brooks Rehabilitation Hospital
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Insiders Buying Hillenbrand And 2 Other Stocks
Although U.S. stocks closed lower on Monday, there were a few notable insider trades. 
Via Benzinga
Earnings Outlook For Helius Medical Tech
Via Benzinga
Helius Medical Technologies Inc. (NASDAQ: HSDT) Near the Top of Equities by Percentage Gain on 9/5
Via Investor Brand Network
Helius Medical Technologies to Present at NobleCon19 Annual Conference
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Helius Medical Technologies, Inc. Reports Third Quarter 2023 Financial Results
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Helius Medical Technologies, Inc. Announces Study Results Demonstrating That PoNS Therapy™ Helps Patients with Traumatic Brain Injury Return to Work
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Helius Medical Technologies, Inc. to Release Third Quarter 2023 Financial Results on November 9, 2023; Announces Extended Cash Runway into Q2 2024
From Helius Medical Technologies, Inc.
Via GlobeNewswire
3 Metaverse Stocks to Invest in for the Internet’s Next Evolution
These metaverse stocks are set to grow from long term growth tailwinds in innovative products and strong financials. 
Via InvestorPlace
Helius Medical Technologies, Inc. Receives Letter of Intent from the Québec Ministry of Health and Social Services to Purchase 30 PoNS® Devices
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Helius Medical Technologies to Participate at Two Upcoming Healthcare Conferences
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Helius Medical Technologies, Inc. Receives UPC Numbers for its PoNS® System and Mouthpiece
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Helius to Bring its Innovative PoNS Therapy for Improvement of Gait in People with MS, to the 2023 Academy of Neurologic Physical Therapy Conference
From Helius Medical Technologies, Inc.
Via GlobeNewswire
University of Montreal’s School of Rehabilitation to Purchase Ten PoNS® Devices for Research Study on Stroke Recovery
-- The study will evaluate the optimal time to use PoNS Therapy™ during a patient’s stroke recovery journey -- 
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation Conference
From Helius Medical Technologies, Inc.
Via GlobeNewswire
Why Hooker Furnishings Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Biocept, Inc. (NASDAQ: BIOC) shares jumped 97.6% to $1.6608 after the company announced non-exclusive licensing agreement for CNSide with Plus Therapeutics. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Core & Main Are Trading Lower By 7%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 114% to $1.47. Palisade Bio transformed GI-focused pipeline through exclusive worldwide licensing agreement with Giiant Pharma, Inc. for multiple... 
Via Benzinga
Why Helius Medical Technologies (HSDT) Stock Is Roaring Higher
Helius Medical Technologies, Inc. (NASDAQ: HSDT) shares are trading higher on Tuesday after the company gained compliance with all applicable Nasdaq listing crite 
Via Benzinga
Why Is 1847 Holdings (EFSH) Stock Down 19% Today?
1847 Holdings (EFSH) stock is taking a beating on Tuesday after the company received a delisting notice from the NYSE American LLC. 
Via InvestorPlace
Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 164% to $1.89 after the completed and launched a technology integration and strategic relationship with global social media platform... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Is TradeUP Acquisition (UPTD) Stock Down 33% Today?
TradeUP Acquisition (UPTD) stock is falling on Tuesday as the company's shares give up gains seen during a recent rally. 
Via InvestorPlace
Why Is Crown ElectroKinetics (CRKN) Stock Up 15% Today?
Crown ElectroKinetics (CRKN) stock is on the rise Tuesday after the company revealed plans for an investor conference call. 
Via InvestorPlace
Why Is Helius Medical Technologies (HSDT) Stock Up 47% Today?
Helius Medical Technologies (HSDT) stock is rising higher on Tuesday as investors react to the company regaining listing compliance. 
Via InvestorPlace
Why NextGen Healthcare Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Gainers Helius Medical Technologies, Inc. (NASDAQ: HSDT) rose 65.3% to $12.20 in pre-market trading after gaining around 9% on Friday. 
Via Benzinga
Helius Medical Technologies, Inc. Compliant with All Applicable Nasdaq Listing Criteria
From Helius Medical Technologies, Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.